Thromboprophylaxis in malignant disease
Open Access
- 1 June 1995
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 82 (6) , 724-725
- https://doi.org/10.1002/bjs.1800820603
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Tissue factor expression correlates with histological grade in human pancreatic cancerBritish Journal of Surgery, 1995
- Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xal units in 2070 patientsBritish Journal of Surgery, 1995
- Prevention and management of venous thrombosisBritish Medical Bulletin, 1994
- Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerThe Lancet, 1994
- Cancer and ThrombosisPathophysiology of Haemostasis and Thrombosis, 1994
- Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgeryThe Lancet, 1993
- Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic CancerNew England Journal of Medicine, 1992
- Lower mortality in cancer patients treated with low-molecular-weight versus standard heparinThe Lancet, 1992
- Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate: Final Report of VA cooperative study # 75Cancer, 1984
- Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of CortisoneScience, 1983